1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

Pathogenesis Of Joint Damage

Pathogenesis Of Joint DamageAlthough the cause of rheumatoid arthritis remains elusive, the destructive features of the disease have been extensively documented and described. The following sections review each key element of disease pathogenesis. They include the infiltration of lymphocytes and macrophages into synovial tissue, hyperplasia of synovial cells, and the enhanced expression of multiple inflammatory mediators, such as cytokines and degradative enzymes.

FIGURE. Pathological changes in the joints of patients with rheumatoid arthritis.

Leukocyte Infiltration in the Joints. As depicted in the left side of (FIGURE. Pathological changes in the joints of patients with rheumatoid arthritis), the healthy joint consists of cartilage layered upon bone that is encased by the synovial membrane, or synovium. By contrast, in the joint of an rheumatoid arthritis patient (FIGURE. Pathological changes in the joints of patients with rheumatoid arthritis, right side), the tissue beneath the synovial lining becomes vascularized and infiltrated with T cells, B cells, and macrophages. Leukocytes also accumulate in the synovial fluid, leading to cartilage destruction and bone damage.

B cells present in the synovial fluid characteristically produce large quantities of immunoglobulin G (IgG) or IgM autoantibodies directed against the constant region of other IgG antibodies. These autoreactive antibodies are termed rheumatoid factors and form immune complexes that activate the complement cascade and phagocytic activity of macrophages. Both CD4+ and CD8+ (cytotoxic) T cells are present in the synovial fluid. Researchers note that the CD4+ subset appears to exist in an activated state, presumably owing to the abundance of IL-2 present in the synovial fluid, which also promotes the initiation of an immune response involving major histocompatibility complex (MHC) class II molecules.

Synovial Cell Hyperplasia and Tissue Destruction. Researchers believe that synovial tissue macrophages and proliferating fibroblasts are major contributors to cartilage and bone destruction because both cell populations produce degradative enzymes, such as matrix metalloproteinas. Synovial fibroblasts produce collagenase and cathepsins as well, and they demonstrate proliferative and invasive properties similar to those of transformed tumor cells.

Monocytes and macrophages may produce large quantities of pro-inflammatory cytokines, including tumor necrosis factor-alpha and IL-1β; IL-8, a potent stimulator of angiogenesis; and monocyte chemoattractant protein-1 (MCP-1). This overabundance of pro-inflammatory cytokines results in persistent inflammation. The clinical success of the tumor necrosis factor-alpha inhibitor etanercept (Amgen/Wyefh/Takeda’ s Enbrel) has resulted in an increased interest in the role of cytokines in rheumatoid arthritis. Table 1 lists some commonly detected cytokines in the synovial tissue and fluid of rheumatoid arthritis patients; TABLE.Select Cytokines Involved in the Pathogenesis of Rheumatoid Arthritis describes the pathophysiological effects of key cytokines. “Current Therapies” discusses the role of tumor necrosis factor-alpha in rheumatoid arthritis pathology.

Cytokines in Rheumatoid Arthritis


Pathogenesis Of Joint DamageThe rheumatoid arthritis synovium contains increased levels of cytokines, prominent among which are tumor necrosis factor-alpha and IL-1. Many other pro-inflammatory cytokines, including IL-6 and IL-18, are also present, as well as anti-inflammatory cytokines such as IL-10, IL-13, and transforming growth factor-beta (TGF-β), suggesting that an imbalance in favor of pro-inflammatory mediators may be a central pathogenic mechanism in rheumatoid arthritis.

An array of cytokines with pro-inflammatory activity in rheumatoid arthritis synovitis have been described that offer therapeutic potential, including IL-6, IL-12, IL-15, and IL-18. Research has demonstrated that the macrophage-produced cytokine IL-1β plays a dominant role in cartilage degradation and joint invasion by synovio-cytes. IL-1 receptor antagonist (IL-lra) expression correlates with the induction of IL-1β. Specifically, IL-lra neutralizes the ability of IL-1β to induce inflammation by binding to IL-1β receptors and inhibiting cellular activation. IL-10, a T helper (Th)2-type cytokine, also has anti-inflammatory properties; it suppresses synthesis of the pro-inflammatory Thl cytokines IL-1β and tumor necrosis factor-alpha. Elevated levels of IL-10 are detected in the synovial fluid of active rheumatoid arthritis patients, and two laboratories have reported that adenoviral transfer of the vlL-10 gene prevents arthritis development in animal models. The results of these studies suggest that IL-lra and IL-10 buffer the pro-inflammatory effects of tumor necrosis factor-alpha and IL-1/?.

IL-6, a pleiotropic cytokine, has a wide range of effects, including stimulating B cells to differentiate into plasma cells in order to produce immunoglobulin and stimulating T lymphocytes to differentiate into cytotoxic T cells. Serum IL-6 concentrations have been shown to correlate with disease activity in active rheumatoid arthritis. IL-12, and the more recently discovered IL-23 and IL-27, comprise a family of structurally related cytokines that regulate cell-mediated immune responses and Thl-type inflammatory reactions. Inhibition of IL-15 and IL-18 represent additional attractive approaches that could block Thl differentiation, inflammatory mediator production, or tumor necrosis factor-alpha expression. IL-15 is produced by endothelial cells and is a potent T-cell chemoattractant.

TABLE . Select Cytokines Detected in the Synovial Tissue of Patients with Rheumatoid Arthritis

Cytokine Primary Sources Targets Activated Degree ofAbundance in

Synovial Tissue

or Fluid

Degree of Effecton Inflammation

or Tissue


TNF-α Monocytes, macrophages Macrophages, fibroblasts High High
IL-1β Monocytes, macrophages Fibroblasts, macrophages High High
IL-2 T lymphocytes T lymphocytes, NK cells Medium Medium
IL-6 Monocytes, macrophages, fibroblasts Lymphocytes Medium Medium
IL-8 Monocytes, macrophages Neutrophils Medium Medium
IL-10 Monocytes, macrophages, T lymphocytes Lymphocytes Medium None
IL-12 Monocytes, macrophages Lymphocytes Low Medium
IL-15 Fibroblasts, monocytes, macrophages Lymphocytes Low Medium
IL-17 T lymphocytes Fibroblasts Low Medium
IL-18 T lymphocytes Monocytes, macrophages, T lymphocytes, NK cells Medium Medium
IFN- y T lymphocytes NK cells Low Medium
TGF-β Fibroblasts, monocytes, macrophages, T lymphocytes Lymphocytes, fibroblasts Medium None
GM-CSF : Monocytes, macrophages, T lymphocytes Neutrophils, macrophages Medium Medium

GM-CSF = Granulocyte-macrophage colony-stimulating factor; IFN = Interferon; IL = Interleukin; NK cell = Natural killer cell; TGF = Transforming growth factor; TNF = Tumor necrosis factor.

It also activates cell adhesion molecule expression on T cells. IL-17, produced by activated CD4+ T cells, is highly expressed in the diseased joint and stimulates formation of bone-resorbing osteoclasts. The pleiotropic cytokine IL-18 acts as a proinflammatory cytokine by inducing tumor necrosis factor-alpha, interferon-gamma (IFN-y), IL-8, IL-2, and prostaglandin production by macrophages and/or T cells, and elevated levels have been detected within the joints of rheumatoid arthritis patients.

Angiogenesis and Rheumatoid Arthritis


Angiogenesis occurs within the synovium early in the pathogenesis of rheumatoid arthritis. These new vessels support the growing synovial tissue, express chemokines that attract additional cells (including leukocytes), and provide an additional source of inflammatory mediators to the synovium. In 1998, researchers proposed that the rheumatoid synovium can be viewed as a rapidly dividing tumorlike structure, a view later endorsed by other researchers. Thus, inhibiting angiogenesis in rheumatoid arthritis may limit the influx of inflammatory cytokines and inhibit synovial proliferation.

TABLE . Select Cytokines Involved in the Pathogenesis of Rheumatoid Arthritis

Mechanism Cytokines Role of Cytokine
Synovial tissue inflammation IFN- y, IL-1β, TNF-α Increased adherence of postcapillary venules
IL-8 Chemotaxis of T cells
IL-1β, IL-2, IL-6, TNF-α T-cell activation and proliferation
IFN- y, IL-1β, IL-2, IL-6, TNF-α B-cell differentiation and antibody formation
GM-CSF, IFN- y, TNF-α Increased expression of HLA antigens
GM-CSF, IFN- y, IL-2 Macrophage activation
Synovial fluid inflammation IFN- y, IL-1β, TNF-α Increased adherence of postcapillary venules
IL-8, TNF-α Chemotactic for PMN
GM-CSF, IL-8,TNF-α Activation of PMN
Synovial proliferation IL-1β,TGF-β Fibroblast growth
TNF-α, TGF-β Neovascularization
Cartilage and bone damage IL-1β, TNF-α Activation of chondrocytes, fibroblasts, and osteoblasts/osteoclasts
Systemic manifestations IL-1β,TNF-α Fever, constitutional symptoms
IL-1β, IL-6, TNF-α Acute-phase reactants

GM-CSF = Granulocyte-macrophage colony-stimulating factor.

HLA = Human leukocyte antigen.

IFN = Interferon.

IL = Interleukin.

PMN = Polymorphonuclear leukocyte.

TGF = Transforming growth factor.

TNF = Tumor necrosis factor.

Leave a Reply

Notify of